Skip to main content

Peer Review reports

From: ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer

Original Submission
4 Jun 2020 Submitted Original manuscript
14 Sep 2020 Reviewed Reviewer Report
7 Jul 2021 Reviewed Reviewer Report - chafik bouzid
28 Jul 2021 Author responded Author comments - Ramadhan Karsono
Resubmission - Version 2
28 Jul 2021 Submitted Manuscript version 2
29 Sep 2021 Reviewed Reviewer Report - chafik bouzid
12 Oct 2021 Author responded Author comments - Ramadhan Karsono
Resubmission - Version 3
12 Oct 2021 Submitted Manuscript version 3
26 Nov 2021 Author responded Author comments - Ramadhan Karsono
Resubmission - Version 4
26 Nov 2021 Submitted Manuscript version 4
Publishing
5 Dec 2021 Editorially accepted
20 Dec 2021 Article published 10.1186/s12885-021-09083-x

You can find further information about peer review here.

Back to article page